StockWatch
·
Pharmaceuticals
Board Meeting14 Nov 2026, 04:24 pm

Orchid Pharma Board Approves Unaudited Financial Results

AI Summary

Orchid Pharma Ltd announced that its Board of Directors, in a meeting held on November 14, 2026, has approved the unaudited limited reviewed standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The auditors' limited review reports on these results were also approved. The meeting commenced at 12:00 Noon IST and concluded at 04:00 P.M. IST.

Key Highlights

  • Board of Directors met on November 14, 2026.
  • Approved unaudited standalone & consolidated financial results.
  • Results are for the quarter and half-year ended September 30, 2026.
  • Auditors' limited review reports were also approved.
  • Meeting concluded after reviewing financial performance.